Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-26-323754

Director sold 261,460 shares at an average $25.51 ($6,670,769)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Kersten Dirk Director 2026-07-27 Sale 10b5-1 −256,072 $25.50 $6,530,451 3,592,184 I
Kersten Dirk Director 2026-07-27 Sale 10b5-1 −5,388 $26.04 $140,319 3,586,796 I
Open-market sales · 261,460 sh · avg $25.51 · $6,670,769
Loading xslF345X06/ownership.xml…